Clinical Trials Directory

Trials / Unknown

UnknownNCT05311293

Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The research group intends to carry out a case-control study to recruit IBS-D patients with anxiety and depression symptoms, by collecting intestinal mucosa for single-cell transcriptome sequencing, collecting peripheral blood for proteomic analysis, the two groups and patient symptoms are associated, and then discover the characteristics of molecular level changes associated with brain-gut axis dysfunction, explore the pathophysiological mechanism of comorbid anxiety and depression and IBS, and discover potential targets for effective treatment. This project can help to construct the colonic single-cell map of IBS-D patients and explore the differentially expressed genes in the colon of IBS patients and their signaling pathways related to neuroregulation, providing an effective therapeutic target for the treatment of comorbid anxiety and depression and IBS.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEndoscopyObserve the extent of colonic lesions and obtain intestinal mucosal samples

Timeline

Start date
2021-11-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2022-04-05
Last updated
2022-04-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05311293. Inclusion in this directory is not an endorsement.